Cabot Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
Cabot wird voraussichtlich ein Umsatzwachstum verzeichnen at 4% per annum.
Wichtige Informationen
n/a
Wachstumsrate der Gewinne
n/a
EPS-Wachstumsrate
Chemicals Gewinnwachstum | 16.8% |
Wachstumsrate der Einnahmen | 4.0% |
Zukünftige Eigenkapitalrendite | 27.4% |
Analystenabdeckung | Low |
Zuletzt aktualisiert | 18 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Cabot: Less Than 5% Annualized Upside
Nov 14Here's Why We Think Cabot (NYSE:CBT) Might Deserve Your Attention Today
Oct 31Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?
Oct 19Improved Earnings Required Before Cabot Corporation (NYSE:CBT) Shares Find Their Feet
Oct 07Cabot (NYSE:CBT) Is Achieving High Returns On Its Capital
Sep 25Calculating The Intrinsic Value Of Cabot Corporation (NYSE:CBT)
Aug 19Cabot Corporation: Now A 'Hold' (Rating Downgrade)
Jul 31Cabot (NYSE:CBT) Will Pay A Dividend Of $0.43
Jul 18Cabot (NYSE:CBT) Looks To Prolong Its Impressive Returns
Jun 23Why Cabot Corporation (NYSE:CBT) Could Be Worth Watching
Jun 09Cabot's (NYSE:CBT) Dividend Will Be Increased To $0.43
May 24Cabot: Reinforcement Materials Strength To Continue To Drive Earnings Forward
May 16Cabot's (NYSE:CBT) Shareholders May Want To Dig Deeper Than Statutory Profit
May 13Cabot's (NYSE:CBT) Upcoming Dividend Will Be Larger Than Last Year's
May 10Here's Why Cabot (NYSE:CBT) Has Caught The Eye Of Investors
May 07We Think Cabot (NYSE:CBT) Can Stay On Top Of Its Debt
Apr 09Cabot Corporation's (NYSE:CBT) CEO Will Probably Have Their Compensation Approved By Shareholders
Mar 01We Ran A Stock Scan For Earnings Growth And Cabot (NYSE:CBT) Passed With Ease
Jan 29Cabot Corp.: Dividend Trends By The Numbers
Jan 18Investors Don't See Light At End Of Cabot Corporation's (NYSE:CBT) Tunnel
Jan 16Returns At Cabot (NYSE:CBT) Appear To Be Weighed Down
Jan 03Cabot (NYSE:CBT) Has A Somewhat Strained Balance Sheet
Dec 20Cabot Corporation: Undervalued Given Margin Expansion Execution
Oct 27Calculating The Intrinsic Value Of Cabot Corporation (NYSE:CBT)
Oct 18Do Cabot's (NYSE:CBT) Earnings Warrant Your Attention?
Oct 05Cabot (NYSE:CBT) Has Some Way To Go To Become A Multi-Bagger
Sep 22Should You Investigate Cabot Corporation (NYSE:CBT) At US$74.12?
Sep 03Cabot (NYSE:CBT) Seems To Use Debt Quite Sensibly
Aug 13Cabot: The Low Upside Potential Discourages Purchases
Aug 10Is Now The Time To Put Cabot (NYSE:CBT) On Your Watchlist?
Jun 18Should You Investigate Cabot Corporation (NYSE:CBT) At US$74.68?
Jun 03Cabot Corporation Can Grow With America
May 25Cabot (NYSE:CBT) Is Increasing Its Dividend To $0.40
May 11Does Cabot (NYSE:CBT) Have A Healthy Balance Sheet?
Apr 06Does Cabot (NYSE:CBT) Deserve A Spot On Your Watchlist?
Mar 10Cabot (NYSE:CBT) Is Very Good At Capital Allocation
Feb 24Cabot (NYSE:CBT) Has Affirmed Its Dividend Of $0.37
Feb 11Cabot Non-GAAP EPS of $0.98 misses by $0.01, revenue of $965M beats by $9.76M
Feb 09Is Cabot Corporation (NYSE:CBT) Potentially Undervalued?
Feb 01Cabot (NYSE:CBT) Is Due To Pay A Dividend Of $0.37
Jan 19Cabot Corporation: Continued Upside Exists, I Say 'Buy'
Jan 19Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
9/30/2027 | 4,521 | N/A | N/A | N/A | 2 |
9/30/2026 | 4,316 | N/A | 385 | 625 | 5 |
9/30/2025 | 4,176 | N/A | 364 | 604 | 5 |
9/30/2024 | 3,994 | 380 | 451 | 692 | N/A |
6/30/2024 | 3,958 | 470 | 399 | 626 | N/A |
3/31/2024 | 3,910 | 443 | 407 | 662 | N/A |
12/31/2023 | 3,924 | 433 | 385 | 648 | N/A |
9/30/2023 | 3,931 | 437 | 351 | 595 | N/A |
6/30/2023 | 4,078 | 300 | 306 | 562 | N/A |
3/31/2023 | 4,259 | 315 | 127 | 353 | N/A |
12/31/2022 | 4,318 | 348 | -15 | 201 | N/A |
9/30/2022 | 4,321 | 206 | -111 | 100 | N/A |
6/30/2022 | 4,113 | 142 | -106 | 95 | N/A |
3/31/2022 | 3,881 | 130 | -65 | 132 | N/A |
12/31/2021 | 3,631 | 98 | -9 | 187 | N/A |
9/30/2021 | 3,409 | 247 | 62 | 257 | N/A |
6/30/2021 | 3,164 | -54 | 103 | 256 | N/A |
3/31/2021 | 2,765 | -144 | 184 | 334 | N/A |
12/31/2020 | 2,633 | -219 | 132 | 293 | N/A |
9/30/2020 | 2,614 | -238 | 177 | 377 | N/A |
6/30/2020 | 2,782 | 65 | 244 | 475 | N/A |
3/31/2020 | 3,109 | 103 | 195 | 441 | N/A |
12/31/2019 | 3,243 | 127 | 269 | 507 | N/A |
9/30/2019 | 3,337 | 155 | 139 | 363 | N/A |
6/30/2019 | 3,360 | 217 | 109 | 321 | N/A |
3/31/2019 | 3,369 | 273 | 51 | 268 | N/A |
12/31/2018 | 3,343 | 77 | -17 | 214 | N/A |
9/30/2018 | 3,242 | -114 | 69 | 298 | N/A |
6/30/2018 | 3,115 | -136 | N/A | 300 | N/A |
3/31/2018 | 2,966 | -177 | N/A | 371 | N/A |
12/31/2017 | 2,826 | 69 | N/A | 286 | N/A |
9/30/2017 | 2,717 | 246 | N/A | 348 | N/A |
6/30/2017 | 2,613 | 225 | N/A | 288 | N/A |
3/31/2017 | 2,529 | 234 | N/A | 262 | N/A |
12/31/2016 | 2,419 | 209 | N/A | 416 | N/A |
9/30/2016 | 2,411 | 145 | N/A | 392 | N/A |
6/30/2016 | 2,463 | 136 | N/A | 516 | N/A |
3/31/2016 | 2,536 | -366 | N/A | 482 | N/A |
12/31/2015 | 2,662 | -388 | N/A | 526 | N/A |
9/30/2015 | 2,871 | -336 | N/A | 499 | N/A |
6/30/2015 | 3,111 | -348 | N/A | 408 | N/A |
3/31/2015 | 3,357 | 150 | N/A | 451 | N/A |
12/31/2014 | 3,561 | 160 | N/A | 389 | N/A |
9/30/2014 | 3,647 | 195 | N/A | 315 | N/A |
6/30/2014 | 3,632 | 214 | N/A | 462 | N/A |
3/31/2014 | 3,593 | 219 | N/A | 484 | N/A |
12/31/2013 | 3,534 | 212 | N/A | 452 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von CBT über der Sparquote liegt (2.6%).
Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von CBT schneller wachsen werden als der Markt US
Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CBT in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: CBTDie Einnahmen des Unternehmens (4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (9% pro Jahr).
Hohe Wachstumseinnahmen: CBTDie Einnahmen des Unternehmens (4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: CBTDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (27.4%)